16:05 EST Applied Therapeutics (APLT) trading halted, news pending
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT:
- Applied Therapeutics price target raised to $13 from $11 at Citi
- RBC says if Applied’s govorestat were to be approved, would likely hear today
- Applied Therapeutics Advances with Govorestat Approvals
- Applied Therapeutics reports Q3 EPS (48c), consensus (16c)
- Applied Therapeutics call volume above normal and directionally bullish